The Scientist

» cancer, immunology and culture

Most Recent

In a pair of clinical studies of psilocybin, the active ingredient in magic mushrooms, participants reported positive changes to their moods and outlooks.

1 Comment

image: Book Excerpt from <em>Redesigning Life</em>

Book Excerpt from Redesigning Life

By | December 1, 2016

In Chapter 8, author John Parrington explores the intersection of precision genome editing and stem cell technologies.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | December 1, 2016

The importance of science innovation, publishing and gender, and more

1 Comment

image: Using Raman Spectroscopy to Identify Cell Types

Using Raman Spectroscopy to Identify Cell Types

By | December 1, 2016

Improvements in instruments and statistical tools allow the capture and analysis of large data sets.

0 Comments

image: 2016 Top 10 Innovations: Honorable Mentions

2016 Top 10 Innovations: Honorable Mentions

By | December 1, 2016

These runners up to the Top 10 Innovations of 2016 caught our judges' attention.

0 Comments

A noninvasive microscopy technique that exploits NADH fluorescence enables researchers to observe how mitochondria alter their shape and arrangement in human tissue.

0 Comments

image: Low Social Status May Weaken Immune System in Monkeys

Low Social Status May Weaken Immune System in Monkeys

By | November 29, 2016

Life at the bottom of the pecking order ramps up inflammation, according to new research, an effect that appears to be reversible.

0 Comments

image: More than 40 New Papers on Epigenetics Published

More than 40 New Papers on Epigenetics Published

By | November 22, 2016

The International Human Epigenome Consortium presents a series of studies on how epigenetics influences immunity, cell lineage determination, and differentiation.

0 Comments

image: Opinion: The Impact Factor, Re-envisioned

Opinion: The Impact Factor, Re-envisioned

By , , and | November 18, 2016

A combination of the traditional metric and the newer h5 index potentiates the scientific community toward more-balanced evaluation. 

2 Comments

image: First CRISPR Clinical Trial Commences

First CRISPR Clinical Trial Commences

By | November 15, 2016

Scientists in China aim to treat 10 people with lung cancer with CRISPR-edited cells.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS